Loading organizations...
Loading organizations...
Biotechnology firm developing immuno-oncologics for metastatic cancer.
IMVAQ Therapeutics has raised $15.0M across 1 funding round.
IMVAQ Therapeutics has raised $15.0M in total across 1 funding round.
IMVAQ Therapeutics has raised $15.0M in total across 1 funding round.
IMVAQ Therapeutics's investors include John Jin.
IMVAQ Therapeutics has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series B in September 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 28, 2020 | $15.0M Series B | John Jin |